DF-Cot 6 Tablet DEFLAZACORT
Introduction to DF-Cot 6 Tablet
The DF-Cot 6 Tablet is a medication primarily used to treat certain muscle disorders. It is especially effective in managing conditions like Duchenne muscular dystrophy (DMD), a disease that causes muscle weakening, in children aged 5 and older.
Composition of DF-Cot 6 Tablet
The active ingredient in DF-Cot 6 Tablet is Deflazacort. This component works by reducing inflammation and suppressing the immune system, helping to manage symptoms associated with muscle disorders.
Uses of DF-Cot 6 Tablet
- Treatment of Duchenne muscular dystrophy (DMD) in children
- Reduction of inflammation in various conditions
- Suppression of the immune system to manage autoimmune diseases
Side effects of DF-Cot 6 Tablet
Common side effects:
- Weight gain
- Increased appetite
- Round face (Cushingoid appearance)
- Upper respiratory infections (common cold)
- Frequent urination
- Nose and throat inflammation
- Excessive hair growth
- Irritability
Serious side effects:
- Allergic reactions such as rash, itching, or swelling
- Severe dizziness
- Trouble breathing
Precautions of DF-Cot 6 Tablet
Before taking DF-Cot 6 Tablet, inform your doctor if you are allergic to it or any of its ingredients. Use with caution during pregnancy and breastfeeding. Do not stop taking the medication suddenly, as it can lead to steroid withdrawal syndrome, causing symptoms like loss of appetite, nausea, vomiting, tiredness, and headache.
How to Take DF-Cot 6 Tablet
- Take the tablet once daily by mouth.
- The recommended dose is about 0.9 mg for each kilogram of body weight.
- It can be taken with or without food.
- Avoid taking it with grapefruit juice.
Conclusion of DF-Cot 6 Tablet
The DF-Cot 6 Tablet is a valuable medication for managing muscle disorders like Duchenne muscular dystrophy. By reducing inflammation and suppressing the immune system, it helps improve the quality of life for those affected. Always follow your doctor's instructions and be aware of potential side effects and precautions.





